Teva Pharmaceutical Industries Limited (FRA:TEV)

FRA:TEV Revenue

Teva Pharmaceutical Industries had revenue of $4.18B USD in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to $16.63B, up 2.07% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

• Revenue (ttm): $16.63B
• Revenue Growth: +2.07%
• P/S Ratio: 1.33
• Revenue / Employee: $465.95K
• Employees: 35,686
• Market Cap: 18.80B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	16.54B	698.00M	4.40%
Dec 31, 2023	15.85B	921.00M	6.17%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%